Epstein Secrets

professionals as needed, from time to time. Boris Nikolic Boris Nikolic is a Managing Director of the General Partner of Biosys. Most recently, Dr. Boris Nikolic served as Chief Advisor for Science and Technology to Bill Gates at bgC3, the private office of Bill Gates, and at the Bill & Melinda Gates Foundati

nvestment team will initially be composed of Boris Nikolic, Hayes Nuss, Peter Corsell and David Schwarz (the "Investment Committee"). We expect that Boris will lead the sourcing, diligence, evaluation and monitoring of portfolio investments. We expect that Hayes will support with investment analysis a

f Advisor for Science and Technology to Bill Gates at bgC3, the private office of Bill Gates, and at the Bill & Melinda Gates Foundation (BMGF). Dr. Nikolic joined the BMGF in October 2007 and bgC3 in April 2010. Dr. Nikolic has led select for-profit and not-for-profit investment activities at the afore

L 2 DRAFT - Jeffery Epstein EFTA00617641 DNA sequencing, estimates a $20 billion addressable market for sequencing technology and applications. McKinsey & Company estimates that genomics will have an economic impact of up to $1.6 trillion on global GDP by 2025. • Smart sensors and remote-monitoring technolog

and Chief Executive Officer Lawson Inc. Japan Boris Nikolic Scientific Advisor Bill & Melinda Gates USA F

hief Executive Officer Lawson Inc. Japan Boris Nikolic Scientific Advisor Bill & Melinda Gates USA F

Vittorio Colao Andrea Coleman Xavier M. Colin Boris Collardi Stephen Coller Paul Collier James Col

arrollo Mexico Zavala SAB Jim Balsillie Chairman and Co-Chief Executive Research in Motion Limited Canada Officer Rolando Balsinde Director McKinsey & Company Spain Beat Balzli Editor-in-Chief HandelsZeitung and Switzerland Finanzrundschau AG Stephane Bancel Chief Executive Officer bioMerieux SA U

ky Newton-King Robin Niblett Mohammad Nibras Dirk Niebel Duncan Niederauer Oliver Niedermaier Bronwyn Nielsen Takeshi Niinami Sauli Niinisto Boris Nikolic Atsutoshi Nishida Keisuke Nishimura Sania Nishtar Sarah Noble Nitin Nohria Nosizwe Nocawe Nokwe Thomas T. Noland Jr Rolf Nonnenmacher Micha

n Nielsen Takeshi Niinami Sauli Niinisto Boris Nikolic Atsutoshi Nishida Keisuke Nishimura Sania Nish

Annual Meeting EFTA_R1_02105165 EFTA02707397 Boris Collardi Chief Executive Officer Bank Julius Ba

Member of the Practice Committee Co-Founder Kibar Holding AS HSBC Asia Pacific Free the Children Swiss Reinsurance Company Ltd Projeto Cies McKinsey & Company Hanwha SolarOne Samsung Engineering Co. Ltd Hanwha Biologics, Hanwha Chemical Corporation Daesung Group Bridgewater Associates LP Mitsubishi C

2/22, Booth, Adam, 10.52M) reports Prime Minister Boris Johnson on Monday "outlined detailed plans in Pa

ecember for vaccinating its population against the coronavirus, the government quietly issued millions of euros in contracts to the consulting giant McKinsey & Company." These deals, "which were not initially disclosed to the public, were intended to help ensure that millions of tiny vaccine vials would make their